The monoclonal anti-CD25 antibody basiliximab for the treatment of progressive systemic sclerosis: An open-label study

M. O. Becker, C. Brückner, H. U. Scherer, N. Wassermann, J. Y. Humrich, L. G. Hanitsch, U. Schneider, A. Kawald, K. Hanke, G. R. Burmester, Gabriela Riemekasten*

*Corresponding author for this work
27 Citations (Scopus)
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Issue number7
Pages (from-to)1340-1341
Number of pages2
Publication statusPublished - 07.2011

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this